This observational study prospectively collect data on chosen dosing, renal function, measured plasma concentrations and adherence to the recommended clinical protocl for ICU patients treated with continuous vancomycin infusion.
Study Type
OBSERVATIONAL
Enrollment
101
Karolinska University Hospital Solna
Stockholm, Sweden
Time (days) from start of treatment to first measurement of a plasma vancomycin concentration between 20 and 25 mg/mL
The title is a full description.
Time frame: Until the end of treatment or discharge from unit
Relationship between time to intended concentration (15-20 mg/L) and adherence to the dosing protocol (% complete adherence).
For each patient the actually administired dose of vancomycin will be compared to the recommendation in the dosing protocol. The time to the intended concentration will be compared between patients with 100% adherence to the recommendations and for patients with dosing not following the recommendations.
Time frame: Until the end of treatment or discharge from unit
Percentage of the total treatment duration with the intended plasma concentration 15-20 mg/L.
The title is a full description.
Time frame: Until the end of treatment or discharge from unit
Relationship between Percentage of the total treatment duration with the intended plasma concentration (15-20 mg/L) and adherence to the dosing protocol.
The title in combination with the description of outcome 2 is a sufficient description.
Time frame: Until the end of treatment or discharge from unit
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.